Global Botulinum Toxin Cdmo Market Size & Outlook, 2026-2033
Global botulinum toxin cdmo market, 2021-2033 (US$M)
Related Markets
Global botulinum toxin cdmo market highlights
- The global botulinum toxin cdmo market generated a revenue of USD 2,492.8 million in 2025 and is expected to reach USD 5,848.6 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 11.5% by 2033.
- In terms of segment, type a botulinum toxin accounted for a revenue of USD 2,442.8 million in 2025.
- Type B Botulinum Toxin is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, China is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 2,492.8 million |
| Market revenue in 2033 | USD 5,848.6 million |
| Growth rate | 11.5% (CAGR from 2026 to 2033) |
| Largest segment | Type a botulinum toxin |
| Fastest growing segment | Type B Botulinum Toxin |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type A Botulinum Toxin, Type B Botulinum Toxin |
Other key industry trends
- In terms of revenue, the North America accounted for 41.7% of the global botulinum toxin cdmo market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, China is the fastest growing regional market and is projected to reach USD 399.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Botulinum Toxin CDMO Market Scope
Botulinum Toxin CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Hikal Ltd. | View profile | 1001-5000 | Seattle, Washington, United States, North America | https://www.hikal.com/ |
| Apeloa Pharmaceutical | View profile | 5001-10000 | Dongyang, Zhejiang, China, Asia | http://www.apeloa.com |
| Cenexi | View profile | 1001-5000 | Fontenay-sous-bois, Ile-de-France, France, Europe | https://www.cenexi.com |
| Grand River Aseptic Manufacturing | View profile | 51-100 | Grand Rapids, Michigan, United States, North America | http://grandriverasepticmfg.com |
| Pharmaron | View profile | - | - | - |
| Cambrex Corporation | View profile | - | - | - |
| Recipharm AB | View profile | - | - | - |
| WuXi Biologics. | View profile | - | - | - |
| Vetter Pharma-Fertigung | View profile | 5001-10000 | Ravensburg, Baden-Wurttemberg, Germany, Europe | https://www.vetter-pharma.com/en |
| Samsung BioLogics | View profile | 1001-5000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | https://www.samsungbiologics.com/ |
| Catalent Inc | View profile | 17219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | https://www.catalent.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
Global botulinum toxin cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin cdmo market will help companies and investors design strategic landscapes.
Type a botulinum toxin was the largest segment with a revenue share of 97.99% in 2025. Horizon Databook has segmented the Global botulinum toxin cdmo market based on type a botulinum toxin, type b botulinum toxin covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Botulinum Toxin CDMO Product Outlook (Revenue, USD Million, 2021-2033)
- Type A Botulinum Toxin
- Type B Botulinum Toxin
- Global Botulinum Toxin CDMO Service Outlook (Revenue, USD Million, 2021-2033)
- Contract Development
- Formulation Development
- Process Development and Scale-Up
- Analytical and Testing Services
- Others
- Contract Manufacturing
- Clinical Manufacturing
- Commercial Manufacturing
- Packaging & Labelling
- Regulatory Affairs
- Supply Chain & Logistics
- Others
- Contract Development
- Global Botulinum Toxin CDMO Application Outlook (Revenue, USD Million, 2021-2033)
- Therapeutic
- Aesthetic
- Global Botulinum Toxin CDMO End Use Outlook (Revenue, USD Million, 2021-2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Aesthetic & Specialty Companies
Reasons to subscribe to Global botulinum toxin cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global botulinum toxin cdmo market databook
-
Our clientele includes a mix of botulinum toxin cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global botulinum toxin cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global botulinum toxin cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global botulinum toxin cdmo market size, by regions, 2021-2033 (US$M)
Top 10 countries: Botulinum toxin cdmo market size, 2025 (US$M)
Global botulinum toxin cdmo market share, by product, 2025 & 2033 (%, US$M)
Botulinum toxin cdmo market: Opportunity assessment by country
Global botulinum toxin cdmo market, by region, 2025 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
